Oxamides as novel NR2B selective NMDA receptor antagonists.
暂无分享,去创建一个
Csilla Horváth | György M Keseru | Csilla Kiss | Sándor Farkas | Anikó Gere | B. Ágai | A. Gere | G. Keserű | C. Kiss | György Domány | S. Kolok | István Borza | Sándor Kolok | Béla Agai | Gizella Barta-Szalai | Eva Bozó | Agnes Proszenyák | Kornél Galgóczy | É. Bozó | S. Farkas | G. Domány | C. Horváth | I. Borza | G. Barta-Szalai | Ágnes Proszenyák | E. Bozo | K. Galgóczy
[1] P. Chazot. The NMDA receptor NR2B subunit: a valid therapeutic target for multiple CNS pathologies. , 2004, Current medicinal chemistry.
[2] B. Ágai,et al. Indole-2-carboxamides as novel NR2B selective NMDA receptor antagonists. , 2003, Bioorganic & medicinal chemistry letters.
[3] B. Ágai,et al. A facile synthesis of 3-(substituted benzyl)piperidines , 2003 .
[4] S. Kolok,et al. Inducible expression and pharmacology of recombinant NMDA receptors, composed of rat NR1a/NR2B subunits , 2003, Neurochemistry International.
[5] L. Meltzer,et al. NR2B selective NMDA receptor antagonists. , 2002, Current pharmaceutical design.
[6] J. Hawkinson,et al. 4-Hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl)piperidine: a novel, potent, and selective NR1/2B NMDA receptor antagonist. , 1999, Journal of medicinal chemistry.
[7] S. Boyce,et al. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn , 1999, Neuropharmacology.
[8] F. Menniti,et al. Antagonists selective for NMDA receptors containing the NR2B subunit. , 1999, Current pharmaceutical design.
[9] J. Kemp,et al. In Vitro Binding Properties in Rat Brain of [3H]Ro 25‐6981, a Potent and Selective Antagonist of NMDA Receptors Containing NR2B Subunits , 1998, Journal of neurochemistry.
[10] J. Kemp,et al. Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro. , 1997, The Journal of pharmacology and experimental therapeutics.
[11] A. Malmberg,et al. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. , 1997, The Journal of pharmacology and experimental therapeutics.
[12] M. Collins,et al. (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses. , 1995, Journal of medicinal chemistry.
[13] S. Hunskaar,et al. Formalin test in mice, a useful technique for evaluating mild analgesics , 1985, Journal of Neuroscience Methods.
[14] A. Janowsky,et al. The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. , 2003, Pharmacology & therapeutics.
[15] H. Mil,et al. The influence of bumetanide on the membrane potential of mouse skeletal muscle cells in isotonic and hypertonic media. , 1997 .